New Podcast Alert: Minddog TV with Matt Nappo

Health care isn’t a one-size-fits-all endeavor. While symptoms often appear to be similar across patient populations, those expressions are typically caused by a set of underlying conditions unique to each person.  

Understanding that, says Dr. Peter Koshland, requires doctors, pharmacists, and other caregivers to treat each patient individually. Sometimes off-the-shelf drugs can be a part of that treatment. At other times, however, more customizable options are needed. 

That’s where compounding pharmacies can play a role in patient therapy. As Dr. Koshland explains in the Minddog TV podcast, compounding pharmacists, such as himself, work with doctors and the patients themselves to better understand symptoms, as well as their root causes. Only then, can therapies be tailored for each individual patient, which can then be monitored and adjusted over time. 

Unfortunately, though, there are institutional roadblocks in place slowing acceptance of these life-changing treatments. One of the main obstacles is the Food and Drug Administration. 

The FDA, says Dr. Koshland, is not equipped to regulate a treatment that is individualized. Hence, one of the very things that’s helping patients—that singularity—is what’s obstructing its acceptance. 

Therefore, to safeguard compounding therapies—which are the only option for many patients—Dr. Koshland and other caregivers urge Americans to learn more at compounding.org.